The Architecture of Circulating Immune Cells Is Dysregulated in People Living With HIV on Long Term Antiretroviral Treatment and Relates With Markers of the HIV-1 Reservoir, Cytomegalovirus, and Microbial Translocation
Long-term changes in the immune system of successfully treated people living with HIV (PLHIV) remain incompletely understood. In this study, we assessed 108 white blood cell (WBC) populations in a cohort of 211 PLHIV on stable antiretroviral therapy and in 56 HIV-uninfected controls using flow cytom...
Main Authors: | , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-04-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2021.661990/full |
id |
doaj-e9c41e13fb5e4b64bc9b68de40eb9eb4 |
---|---|
record_format |
Article |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Lisa Van de Wijer Wouter A. van der Heijden Rob ter Horst Martin Jaeger Wim Trypsteen Sofie Rutsaert Bram van Cranenbroek Esther van Rijssen Irma Joosten Leo Joosten Linos Vandekerckhove Till Schoofs Jan van Lunzen Mihai G. Netea Mihai G. Netea Hans J.P.M. Koenen André J.A.M. van der Ven Quirijn de Mast |
spellingShingle |
Lisa Van de Wijer Wouter A. van der Heijden Rob ter Horst Martin Jaeger Wim Trypsteen Sofie Rutsaert Bram van Cranenbroek Esther van Rijssen Irma Joosten Leo Joosten Linos Vandekerckhove Till Schoofs Jan van Lunzen Mihai G. Netea Mihai G. Netea Hans J.P.M. Koenen André J.A.M. van der Ven Quirijn de Mast The Architecture of Circulating Immune Cells Is Dysregulated in People Living With HIV on Long Term Antiretroviral Treatment and Relates With Markers of the HIV-1 Reservoir, Cytomegalovirus, and Microbial Translocation Frontiers in Immunology HIV Th17 & Tregs cells CD4+/CD8+ lymphocytes B cell HIV reservoir CMV |
author_facet |
Lisa Van de Wijer Wouter A. van der Heijden Rob ter Horst Martin Jaeger Wim Trypsteen Sofie Rutsaert Bram van Cranenbroek Esther van Rijssen Irma Joosten Leo Joosten Linos Vandekerckhove Till Schoofs Jan van Lunzen Mihai G. Netea Mihai G. Netea Hans J.P.M. Koenen André J.A.M. van der Ven Quirijn de Mast |
author_sort |
Lisa Van de Wijer |
title |
The Architecture of Circulating Immune Cells Is Dysregulated in People Living With HIV on Long Term Antiretroviral Treatment and Relates With Markers of the HIV-1 Reservoir, Cytomegalovirus, and Microbial Translocation |
title_short |
The Architecture of Circulating Immune Cells Is Dysregulated in People Living With HIV on Long Term Antiretroviral Treatment and Relates With Markers of the HIV-1 Reservoir, Cytomegalovirus, and Microbial Translocation |
title_full |
The Architecture of Circulating Immune Cells Is Dysregulated in People Living With HIV on Long Term Antiretroviral Treatment and Relates With Markers of the HIV-1 Reservoir, Cytomegalovirus, and Microbial Translocation |
title_fullStr |
The Architecture of Circulating Immune Cells Is Dysregulated in People Living With HIV on Long Term Antiretroviral Treatment and Relates With Markers of the HIV-1 Reservoir, Cytomegalovirus, and Microbial Translocation |
title_full_unstemmed |
The Architecture of Circulating Immune Cells Is Dysregulated in People Living With HIV on Long Term Antiretroviral Treatment and Relates With Markers of the HIV-1 Reservoir, Cytomegalovirus, and Microbial Translocation |
title_sort |
architecture of circulating immune cells is dysregulated in people living with hiv on long term antiretroviral treatment and relates with markers of the hiv-1 reservoir, cytomegalovirus, and microbial translocation |
publisher |
Frontiers Media S.A. |
series |
Frontiers in Immunology |
issn |
1664-3224 |
publishDate |
2021-04-01 |
description |
Long-term changes in the immune system of successfully treated people living with HIV (PLHIV) remain incompletely understood. In this study, we assessed 108 white blood cell (WBC) populations in a cohort of 211 PLHIV on stable antiretroviral therapy and in 56 HIV-uninfected controls using flow cytometry. We show that marked differences exist in T cell maturation and differentiation between PLHIV and HIV-uninfected controls: PLHIV had reduced percentages of CD4+ T cells and naïve T cells and increased percentages of CD8+ T cells, effector T cells, and T helper 17 (Th17) cells, together with increased Th17/regulatory T cell (Treg) ratios. PLHIV also exhibited altered B cell maturation with reduced percentages of memory B cells and increased numbers of plasmablasts. Determinants of the T and B cell composition in PLHIV included host factors (age, sex, and smoking), markers of the HIV reservoir, and CMV serostatus. Moreover, higher circulating Th17 percentages were associated with higher plasma concentrations of interleukin (IL) 6, soluble CD14, the gut homing chemokine CCL20, and intestinal fatty acid binding protein (IFABP). The changes in circulating lymphocytes translated into functional changes with reduced interferon (IFN)- γ responses of peripheral blood mononuclear cells to stimulation with Candida albicans and Mycobacterium tuberculosis. In conclusion, this comprehensive analysis confirms the importance of persistent abnormalities in the number and function of circulating immune cells in PLHIV on stable treatment. |
topic |
HIV Th17 & Tregs cells CD4+/CD8+ lymphocytes B cell HIV reservoir CMV |
url |
https://www.frontiersin.org/articles/10.3389/fimmu.2021.661990/full |
work_keys_str_mv |
AT lisavandewijer thearchitectureofcirculatingimmunecellsisdysregulatedinpeoplelivingwithhivonlongtermantiretroviraltreatmentandrelateswithmarkersofthehiv1reservoircytomegalovirusandmicrobialtranslocation AT wouteravanderheijden thearchitectureofcirculatingimmunecellsisdysregulatedinpeoplelivingwithhivonlongtermantiretroviraltreatmentandrelateswithmarkersofthehiv1reservoircytomegalovirusandmicrobialtranslocation AT robterhorst thearchitectureofcirculatingimmunecellsisdysregulatedinpeoplelivingwithhivonlongtermantiretroviraltreatmentandrelateswithmarkersofthehiv1reservoircytomegalovirusandmicrobialtranslocation AT martinjaeger thearchitectureofcirculatingimmunecellsisdysregulatedinpeoplelivingwithhivonlongtermantiretroviraltreatmentandrelateswithmarkersofthehiv1reservoircytomegalovirusandmicrobialtranslocation AT wimtrypsteen thearchitectureofcirculatingimmunecellsisdysregulatedinpeoplelivingwithhivonlongtermantiretroviraltreatmentandrelateswithmarkersofthehiv1reservoircytomegalovirusandmicrobialtranslocation AT sofierutsaert thearchitectureofcirculatingimmunecellsisdysregulatedinpeoplelivingwithhivonlongtermantiretroviraltreatmentandrelateswithmarkersofthehiv1reservoircytomegalovirusandmicrobialtranslocation AT bramvancranenbroek thearchitectureofcirculatingimmunecellsisdysregulatedinpeoplelivingwithhivonlongtermantiretroviraltreatmentandrelateswithmarkersofthehiv1reservoircytomegalovirusandmicrobialtranslocation AT esthervanrijssen thearchitectureofcirculatingimmunecellsisdysregulatedinpeoplelivingwithhivonlongtermantiretroviraltreatmentandrelateswithmarkersofthehiv1reservoircytomegalovirusandmicrobialtranslocation AT irmajoosten thearchitectureofcirculatingimmunecellsisdysregulatedinpeoplelivingwithhivonlongtermantiretroviraltreatmentandrelateswithmarkersofthehiv1reservoircytomegalovirusandmicrobialtranslocation AT leojoosten thearchitectureofcirculatingimmunecellsisdysregulatedinpeoplelivingwithhivonlongtermantiretroviraltreatmentandrelateswithmarkersofthehiv1reservoircytomegalovirusandmicrobialtranslocation AT linosvandekerckhove thearchitectureofcirculatingimmunecellsisdysregulatedinpeoplelivingwithhivonlongtermantiretroviraltreatmentandrelateswithmarkersofthehiv1reservoircytomegalovirusandmicrobialtranslocation AT tillschoofs thearchitectureofcirculatingimmunecellsisdysregulatedinpeoplelivingwithhivonlongtermantiretroviraltreatmentandrelateswithmarkersofthehiv1reservoircytomegalovirusandmicrobialtranslocation AT janvanlunzen thearchitectureofcirculatingimmunecellsisdysregulatedinpeoplelivingwithhivonlongtermantiretroviraltreatmentandrelateswithmarkersofthehiv1reservoircytomegalovirusandmicrobialtranslocation AT mihaignetea thearchitectureofcirculatingimmunecellsisdysregulatedinpeoplelivingwithhivonlongtermantiretroviraltreatmentandrelateswithmarkersofthehiv1reservoircytomegalovirusandmicrobialtranslocation AT mihaignetea thearchitectureofcirculatingimmunecellsisdysregulatedinpeoplelivingwithhivonlongtermantiretroviraltreatmentandrelateswithmarkersofthehiv1reservoircytomegalovirusandmicrobialtranslocation AT hansjpmkoenen thearchitectureofcirculatingimmunecellsisdysregulatedinpeoplelivingwithhivonlongtermantiretroviraltreatmentandrelateswithmarkersofthehiv1reservoircytomegalovirusandmicrobialtranslocation AT andrejamvanderven thearchitectureofcirculatingimmunecellsisdysregulatedinpeoplelivingwithhivonlongtermantiretroviraltreatmentandrelateswithmarkersofthehiv1reservoircytomegalovirusandmicrobialtranslocation AT quirijndemast thearchitectureofcirculatingimmunecellsisdysregulatedinpeoplelivingwithhivonlongtermantiretroviraltreatmentandrelateswithmarkersofthehiv1reservoircytomegalovirusandmicrobialtranslocation AT lisavandewijer architectureofcirculatingimmunecellsisdysregulatedinpeoplelivingwithhivonlongtermantiretroviraltreatmentandrelateswithmarkersofthehiv1reservoircytomegalovirusandmicrobialtranslocation AT wouteravanderheijden architectureofcirculatingimmunecellsisdysregulatedinpeoplelivingwithhivonlongtermantiretroviraltreatmentandrelateswithmarkersofthehiv1reservoircytomegalovirusandmicrobialtranslocation AT robterhorst architectureofcirculatingimmunecellsisdysregulatedinpeoplelivingwithhivonlongtermantiretroviraltreatmentandrelateswithmarkersofthehiv1reservoircytomegalovirusandmicrobialtranslocation AT martinjaeger architectureofcirculatingimmunecellsisdysregulatedinpeoplelivingwithhivonlongtermantiretroviraltreatmentandrelateswithmarkersofthehiv1reservoircytomegalovirusandmicrobialtranslocation AT wimtrypsteen architectureofcirculatingimmunecellsisdysregulatedinpeoplelivingwithhivonlongtermantiretroviraltreatmentandrelateswithmarkersofthehiv1reservoircytomegalovirusandmicrobialtranslocation AT sofierutsaert architectureofcirculatingimmunecellsisdysregulatedinpeoplelivingwithhivonlongtermantiretroviraltreatmentandrelateswithmarkersofthehiv1reservoircytomegalovirusandmicrobialtranslocation AT bramvancranenbroek architectureofcirculatingimmunecellsisdysregulatedinpeoplelivingwithhivonlongtermantiretroviraltreatmentandrelateswithmarkersofthehiv1reservoircytomegalovirusandmicrobialtranslocation AT esthervanrijssen architectureofcirculatingimmunecellsisdysregulatedinpeoplelivingwithhivonlongtermantiretroviraltreatmentandrelateswithmarkersofthehiv1reservoircytomegalovirusandmicrobialtranslocation AT irmajoosten architectureofcirculatingimmunecellsisdysregulatedinpeoplelivingwithhivonlongtermantiretroviraltreatmentandrelateswithmarkersofthehiv1reservoircytomegalovirusandmicrobialtranslocation AT leojoosten architectureofcirculatingimmunecellsisdysregulatedinpeoplelivingwithhivonlongtermantiretroviraltreatmentandrelateswithmarkersofthehiv1reservoircytomegalovirusandmicrobialtranslocation AT linosvandekerckhove architectureofcirculatingimmunecellsisdysregulatedinpeoplelivingwithhivonlongtermantiretroviraltreatmentandrelateswithmarkersofthehiv1reservoircytomegalovirusandmicrobialtranslocation AT tillschoofs architectureofcirculatingimmunecellsisdysregulatedinpeoplelivingwithhivonlongtermantiretroviraltreatmentandrelateswithmarkersofthehiv1reservoircytomegalovirusandmicrobialtranslocation AT janvanlunzen architectureofcirculatingimmunecellsisdysregulatedinpeoplelivingwithhivonlongtermantiretroviraltreatmentandrelateswithmarkersofthehiv1reservoircytomegalovirusandmicrobialtranslocation AT mihaignetea architectureofcirculatingimmunecellsisdysregulatedinpeoplelivingwithhivonlongtermantiretroviraltreatmentandrelateswithmarkersofthehiv1reservoircytomegalovirusandmicrobialtranslocation AT mihaignetea architectureofcirculatingimmunecellsisdysregulatedinpeoplelivingwithhivonlongtermantiretroviraltreatmentandrelateswithmarkersofthehiv1reservoircytomegalovirusandmicrobialtranslocation AT hansjpmkoenen architectureofcirculatingimmunecellsisdysregulatedinpeoplelivingwithhivonlongtermantiretroviraltreatmentandrelateswithmarkersofthehiv1reservoircytomegalovirusandmicrobialtranslocation AT andrejamvanderven architectureofcirculatingimmunecellsisdysregulatedinpeoplelivingwithhivonlongtermantiretroviraltreatmentandrelateswithmarkersofthehiv1reservoircytomegalovirusandmicrobialtranslocation AT quirijndemast architectureofcirculatingimmunecellsisdysregulatedinpeoplelivingwithhivonlongtermantiretroviraltreatmentandrelateswithmarkersofthehiv1reservoircytomegalovirusandmicrobialtranslocation |
_version_ |
1721521217584758784 |
spelling |
doaj-e9c41e13fb5e4b64bc9b68de40eb9eb42021-04-19T13:50:52ZengFrontiers Media S.A.Frontiers in Immunology1664-32242021-04-011210.3389/fimmu.2021.661990661990The Architecture of Circulating Immune Cells Is Dysregulated in People Living With HIV on Long Term Antiretroviral Treatment and Relates With Markers of the HIV-1 Reservoir, Cytomegalovirus, and Microbial TranslocationLisa Van de Wijer0Wouter A. van der Heijden1Rob ter Horst2Martin Jaeger3Wim Trypsteen4Sofie Rutsaert5Bram van Cranenbroek6Esther van Rijssen7Irma Joosten8Leo Joosten9Linos Vandekerckhove10Till Schoofs11Jan van Lunzen12Mihai G. Netea13Mihai G. Netea14Hans J.P.M. Koenen15André J.A.M. van der Ven16Quirijn de Mast17Department of Internal Medicine and Radboud Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, NetherlandsDepartment of Internal Medicine and Radboud Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, NetherlandsDepartment of Internal Medicine and Radboud Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, NetherlandsDepartment of Internal Medicine and Radboud Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, NetherlandsHIV Cure Research Center, Department of Internal Medicine and Paediatrics, Faculty of Medicine and Health Sciences, Ghent University and Ghent University Hospital, Ghent, BelgiumHIV Cure Research Center, Department of Internal Medicine and Paediatrics, Faculty of Medicine and Health Sciences, Ghent University and Ghent University Hospital, Ghent, BelgiumLaboratory for Medical Immunology, Department of Laboratory Medicine, Radboud University Medical Center, Nijmegen, NetherlandsLaboratory for Medical Immunology, Department of Laboratory Medicine, Radboud University Medical Center, Nijmegen, NetherlandsLaboratory for Medical Immunology, Department of Laboratory Medicine, Radboud University Medical Center, Nijmegen, NetherlandsDepartment of Internal Medicine and Radboud Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, NetherlandsHIV Cure Research Center, Department of Internal Medicine and Paediatrics, Faculty of Medicine and Health Sciences, Ghent University and Ghent University Hospital, Ghent, BelgiumViiV Healthcare, Brentford, United KingdomViiV Healthcare, Brentford, United KingdomDepartment of Internal Medicine and Radboud Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, NetherlandsDepartment for Genomics & Immunoregulation, Life and Medical Sciences 12 Institute (LIMES), University of Bonn, Bonn, GermanyLaboratory for Medical Immunology, Department of Laboratory Medicine, Radboud University Medical Center, Nijmegen, NetherlandsDepartment of Internal Medicine and Radboud Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, NetherlandsDepartment of Internal Medicine and Radboud Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, NetherlandsLong-term changes in the immune system of successfully treated people living with HIV (PLHIV) remain incompletely understood. In this study, we assessed 108 white blood cell (WBC) populations in a cohort of 211 PLHIV on stable antiretroviral therapy and in 56 HIV-uninfected controls using flow cytometry. We show that marked differences exist in T cell maturation and differentiation between PLHIV and HIV-uninfected controls: PLHIV had reduced percentages of CD4+ T cells and naïve T cells and increased percentages of CD8+ T cells, effector T cells, and T helper 17 (Th17) cells, together with increased Th17/regulatory T cell (Treg) ratios. PLHIV also exhibited altered B cell maturation with reduced percentages of memory B cells and increased numbers of plasmablasts. Determinants of the T and B cell composition in PLHIV included host factors (age, sex, and smoking), markers of the HIV reservoir, and CMV serostatus. Moreover, higher circulating Th17 percentages were associated with higher plasma concentrations of interleukin (IL) 6, soluble CD14, the gut homing chemokine CCL20, and intestinal fatty acid binding protein (IFABP). The changes in circulating lymphocytes translated into functional changes with reduced interferon (IFN)- γ responses of peripheral blood mononuclear cells to stimulation with Candida albicans and Mycobacterium tuberculosis. In conclusion, this comprehensive analysis confirms the importance of persistent abnormalities in the number and function of circulating immune cells in PLHIV on stable treatment.https://www.frontiersin.org/articles/10.3389/fimmu.2021.661990/fullHIVTh17 & Tregs cellsCD4+/CD8+ lymphocytesB cellHIV reservoirCMV |